Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 5,725,593 $ 8,186,194
Investments 5,950,638 4,933,550
Other current assets 106,819 45,982
Total current assets 11,783,050 13,165,726
Operating lease right-of-use asset 49,376 61,228
Total assets 11,832,426 13,226,954
Current liabilities:    
Accounts payable, accrued expenses and other current liabilities 2,887,765 3,128,894
Total current liabilities 2,887,765 3,128,894
Non-current operating lease liability 0 8,408
Total liabilities 2,887,765 3,137,302
Stockholders' equity    
Common stock, par value of $0.001 per share, 40,000,000 shares authorized, 13,222,056 and 12,946,573 shares issued and outstanding at March 31, 2023, and December 31, 2022, respectively 13,222 12,947
Additional paid-in capital 63,138,229 61,871,784
Accumulated other comprehensive income 31,787 8,942
Accumulated deficit (54,238,577) (51,804,021)
Total stockholders' equity 8,944,661 10,089,652
Total liabilities and stockholders' equity $ 11,832,426 $ 13,226,954